Molbio Diagnostics Limited (NSE:MOLBIO)
India flag India · Delayed Price · Currency is INR
1,319.90
-16.10 (-1.21%)
Nov 11, 2026, 1:15 PM IST

Molbio Diagnostics Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Net Income
1,5441,6661,4511,020-7.26
Depreciation & Amortization
768.83625.81432.36395.45312.41
Other Amortization
10.5910.5913.1714.634.81
Loss (Gain) From Sale of Assets
3.333.940.63-3.660.44
Asset Writedown & Restructuring Costs
--35.16263.599.78
Loss (Gain) From Sale of Investments
---0.02-
Loss (Gain) on Equity Investments
5.9521.9819.70.17-
Provision & Write-off of Bad Debts
29.43134.98155.96379.037.12
Other Operating Activities
174.12358.2-55.62227.91-238.15
Change in Accounts Receivable
2,955-1,4611,372-2,639634.17
Change in Inventory
37.98-283.22-1,341150.13-319.79
Change in Accounts Payable
-248.29250.461,365321353.56
Change in Other Net Operating Assets
-732.36-824.3-577.7-32.62-115.77
Operating Cash Flow
4,568503.852,87195.7641.32
Operating Cash Flow Growth
--82.45%2900.03%-85.08%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Capital Expenditures
-610.61-500.22-546.61-263.68-144.98
Sale of Property, Plant & Equipment
4.274.290.55-0.25
Cash Acquisitions
-----390.29
Sale (Purchase) of Real Estate
----271.69-
Investment in Securities
-1,693-483.73-610.0778.52-83
Other Investing Activities
111.0547.44-70.48.9213.36
Investing Cash Flow
-2,188-932.22-1,227-450.1-397.32

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Short-Term Debt Issued
-979.740.38--
Long-Term Debt Issued
-2,24827.48269.1114.56
Total Debt Issued
2,5583,22727.86269.1114.56
Short-Term Debt Repaid
----416.96-149.64
Long-Term Debt Repaid
--192.65-166.38-77.05-40.11
Lease Payments
-92.86-82.73-57.22-35.91-24.86
Total Debt Repaid
-1,048-192.65-166.38-494.01-189.75
Net Debt Issued (Repaid)
1,5103,035-138.52-224.9-175.19
Issuance of Common Stock
2,000---400.01
Other Financing Activities
-458.88-274.13-122.95-90.63-42.39
Financing Cash Flow
3,0512,761-261.47-315.53182.43

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Foreign Exchange Rate Adjustments
178.91148.18---
Miscellaneous Cash Flow Adjustments
244.94244.94---
Net Cash Flow
5,8542,7251,383-669.93426.43

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Free Cash Flow
3,9573.632,324-167.98496.34
Free Cash Flow Growth
--99.84%---
Free Cash Flow Margin
27.61%0.03%22.78%-2.01%14.93%
Free Cash Flow Per Share
34.990.0320.61-1.494.41
Levered Free Cash Flow
--239.82,589-319.5-
Unlevered Free Cash Flow
--43.592,689-233.94-
Free Cash Flow After Leases
3,864-79.12,267-203.89471.48

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash Interest Paid
385.69274.13129.45121.842.39
Cash Income Tax Paid
804.22706.83798.66434.65381.44
Change in Working Capital
2,012-2,318818.64-2,201552.17